Decline depth
-35.7%
From rolling 252-day high of $89.98, 288d ago.
Past the 30% Amber threshold.
-35.7%
from rolling 252-day high of $89.98 set 2025-07-30 · 288d ago
Current
$57.82
Decline depth
-35.7%
Decline σ
4.7σ
TFC
1/5 bearish
Rolling 252-day high
Up day
Down day
Last 90 trading days · data from Alpaca
Structural break signals
DXCM qualifies for the Amber List on decline depth.
Time-frame continuity
1/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3.
Decline sigma
4.7σ
Drop from local high over the last 20 bars, expressed in units of the stock's typical daily volatility (2.5% per day).
Past the ≥4σ Watch threshold.
The structural read
What price action says about DXCM.
DXCM qualifies for the Amber List on decline depth — down -35.7% from its rolling 252-day high.
Cross-confirmation: decline sigma also reads 4.7σ over 20 bars.
Upstream TFC read: bearish alignment, current phase daily. Last bar types — daily 2D (red), weekly 2D (red), monthly 1 (red).
Earnings on file: 2026-04-30. Tiering is unaffected by earnings dates — listings reflect price structure only.
52-week range
52W low $54.11
10.3% of range
52W high $89.98
Sector context · Healthcare
182 other Healthcare tickers are on Broken Stocks.
93
Red List
42
Amber
47
Watch
-35.8%
Median decline
Worst in sector: OPRX (-76.7%). Least-bad: ANIP (-20.0%). See all Healthcare listings →
Related — same sector
Closest decliners to DXCM
Red List
VNDA
Vanda Pharmaceuticals Inc.
Amber List
CRSP
CRISPR Therapeutics AG
Amber List Recovering
STVN
Stevanato Group S.p.A.
Amber List Recovering
CORT
Corcept Therapeutics Incorporat
Red List
TENX
Tenax Therapeutics, Inc.
Red List
ARVN
Arvinas, Inc.
Questions about DXCM
What people ask.
Why is DXCM on Broken Stocks?
DXCM qualifies for the Amber List on decline depth. It is down -35.7% from its rolling 252-day high of $89.98, set on 2025-07-30 — 288d ago.
Is DXCM a falling knife?
Not by the strict technical definition. DXCM is down -35.7% from its 52-week high, but that high was set 288d ago — more than 120 days. A falling knife is usually a recent breakdown from a fresh high, not an established multi-quarter downtrend. DXCM is still on the Amber List for decline depth, but the freshness component of a falling knife is missing.
Is DXCM a buy?
Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.
Where is DXCM trading inside its 52-week range?
At $57.82, DXCM sits 10.3% of the way from its 52-week low ($54.11) to its 52-week high ($89.98). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.
How fast has DXCM been declining?
The current 35.7% decline accrued over 288d, which annualizes to roughly -45.2% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.
How does DXCM compare to its sector?
There are 182 other Healthcare tickers on Broken Stocks: 93 Red, 42 Amber, 47 Watch, with 55 showing recovering structural signals. Median sector decline is -35.8% — DXCM's decline is shallower than the sector median.
Does DXCM's earnings date affect its tier?
No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-04-30) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.